Cemat A/S
5.9.2025 15:40:50 CEST | Globenewswire | Press release
No. 15/2025 - Closely related persons transactions
No. 15/2025 - Closely related persons transactions
Nasdaq Copenhagen
Nikolaj Plads 6
DK-1067 Copenhagen K
Copenhagen, 5 September 2025
ANNOUNCEMENT no. 15/2025
Closely related persons transactions
Pursuant to Article 19 of the market abuse regulation Cemat A/S hereby announces the following information received 5 September 2025.
| Details of the person discharging managerial responsibilities/person closely associated | ||
| Name: | Peter Tærø Nielsen | |
| Reason for the notification: | ||
| Position/status: | Closely related person to Joanna Lucyna Iwanowska-Nielsen, member of the board of directors in the company | |
| Initial notification/Amendment: | Initial | |
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| Name: | Cemat A/S | |
| LEI: | 213800899MWAZT9KQZ78 | |
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| Description of the financial instrument, type of instrument: | Shares | |
| Identification code: | ISIN DK0010271584 | |
| Nature of the transaction: | Purchase of shares | |
| Price(s): | DKK 101,954.20 | |
| Volume (s): | 100,000 | |
| Aggregated information: | ||
| 100,000 | |
| DKK 101,954.20, equivalent to DKK 1.019542 per share | |
| Date of the transaction: | 4 September 2025 | |
| Place of the transaction: | Nasdaq Copenhagen, XCSE | |
Cemat A/S
Jaroslaw Pawel Lipinski
CEO
This announcement has been prepared in a Danish-language and an English-language
version. In case of doubt, the Danish version prevails.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
F. Hoffmann-La Roche Ltd25.10.2026 16:30:00 CET | Press release
Roche’s divarasib demonstrated best-in-class efficacy, advancing the standard of care in previously treated KRAS G12C-mutated lung cancer
Genmab A/S25.10.2026 12:00:00 CET | Press release
Genmab Announces Updated Follow-Up Analyses from Phase 2 Study of Petosemtamab Demonstrate Meaningful Objective Response Rates in Patients with Metastatic Colorectal Cancer
Genmab A/S24.10.2026 13:00:00 CEST | Press release
Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
ASYAD24.10.2026 12:47:36 CEST | Press release
Asyad Group to Host Muscat Maritime Resilience Forum to Strengthen Global Trade Networks
King Faisal Specialist Hospital & Research Centre24.10.2026 11:00:00 CEST | Press release
KFSH Extends Emergency Access Through Virtual Care and Specialist Coordination
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom